Overcoming Barriers to Clozapine

Deanna L. Kelly, PharmD, BCPP

Professor of Psychiatry, Treatment Research Program (TRP)
Maryland Psychiatric Research Center (MPRC)
University of Maryland School of Medicine

Learning Objectives

Discuss the utility of clozapine in the treatment resistant schizophrenia
List significant barriers to the use of clozapine
Recognize new data and strategies to overcome some barriers to clozapine use including point of care monitoring, new plasma level assay, and emerging data in patients with Benign Ethnic Neutropenia

Activity Description

This program consists of 1 video and downloadable resources in PDF format. To begin, take the ungraded pre-test for the module below. Review the video and handout(s), then complete the post-test ( > 70% within 5 attempts) and evaluation. CPE credit will automatically upload to CPE Monitor (allow 7 days).

Continuing Education Credit

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.10 CEUs (1.00 contact hour) of continuing education credit. In order to receive 1.00 contact hour of CE credit, the participant must complete the online pre-test (ungraded), watch the included video in its entirety, pass the online post-test ( > 70% within 5 attempts), and complete the online evaluation. Upon successful completion of the course evaluation, continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 7 days).

Please make sure NABP profile ID and date of birth (month/year) are entered correctly under learner's profile in this system.

Fee

$15.00

CE Hours

1.00

CE Units

0.100

Activity Type

Knowledge

Overcoming Barriers to Clozapine

About the Faculty

Deanna L. Kelly, PharmD, BCPP
Professor of Psychiatry Director, Treatment Research Program (TRP)
Maryland Psychiatric Research Center (MPRC)
University of Maryland School of Medicine

Deanna L. Kelly, Pharm.D., BCPP is a Tenured Professor of Psychiatry at the University of Maryland Baltimore School of Medicine and is currently Director of the Treatment Research Program at the Maryland Psychiatric Research Center (MPRC). Dr. Kelly has coauthored and authored 20 books/chapters, published over 220 peer-reviewed articles, presented over 250 scientific posters and has given over 175 invited lectures. In 2017 she was awarded the prestigious Maltz Prize for Innovative and Promising Schizophrenia Research by the Brain and Behavior Research Foundation. https://www.youtube.com/watch?v=y-9lOpPUdg0 She was recently awarded the unsolicited prestigious Method to Extend Research in Time (MERIT) award (R37) from the National Institutes of Mental Health (NIMH) recognizing her research competence and productivity as distinctly superior. Additionally, her work and scientific expertise has been featured in the New York Times, Women’s Day Magazine, Gluten-Free Living, Vice Media, Clinical Psychiatry News, Psychiatric News and Medscape Medical News.

Disclosure: Dr. Kelly has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.

Activity Number

0067-0000-21-202-H04-P

Release Date: Oct 21, 2021

Credit Expiration Date: Oct 20, 2024

CE Hours

1.00